top-left-banner

Saturday, Nov 01st

Last update02:53:21 PM GMT

TwitterLinkedinYoutubeGoogleFeed

Banner

User1

User2c

User3

You are here: BioMedTech

BioMedTech

Angels boost Sphere Fluidics’ £1.6m round

Sphere Medical CEO Frank Craig Cambridge UK life science startup, Sphere Fluidics, is hiring fast after closing a £1.6m funding round – which included a £133k investment by a syndicate of London Business Angels group.

TSB backs new Cambridge TB diagnostic

Dr Paul RodgersThe Technology Strategy Board (TSB) has pumped unspecified funding into Cambridge UK business ProteinLogic to accelerate research into a novel diagnostic test for TB.

Cambridge in £11m fight for war vets

Addenbrooke’s Hospital. Image by D.DinneenA Cambridge centre is among NHS services across the country set to benefit from additional funding to improve prosthetic and rehabilitation services for ex-servicemen and women through harnessing innovative technology.

Chinese government takes Cambridge bug tester

ProtoCOL 3The Chinese government has turned to Cambridge UK technology to accelerate and improve vaccine and antibiotic testing by microbiologists at regional laboratories across China.

Team boxes clever with smartpack for pharma

Team’s unboxing design concept helps patients cope with the emotional and physical demands of self-injectionCambridge innovation hothouse Team Consulting unveils groundbreaking new pharma packaging in Paris tomorrow to help patients lose their fear of unwrapping self-injection and other daunting medical devices.

Cambridge firm is sleekness in Seattle

Cambridge HealthcareCambridge Healthcare, the UK startup whose technology is helping to revolutionise patient care, has opened a Seattle office to piggy-back reform in the United States.

Vernalis lands $1.5m Genentech milestone

Pharma technology business Vernalis plc, with research operations in Cambridge, has received a $1.5 million milestone payment under a drug discovery collaboration with Roche Group company, Genentech.

Vernalis CEO Ian GarlandGenentech was a trailblazer for the infant UK biotechnology sector when it was founded more than 30 years ago. It is headquartered in San Francisco.

Antibodies boost in translational medicine race

Chairman and CEO, Andy SandhamCambridge antibody technology powerhouse, Kymab, has founded a global academic think tank to accelerate research into translational medicines.

Page 52 of 130